Login    Join free Add to favorites    中文
home > news > Oxford global: 4th Annual Drug Discovery USA Congress
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
Oxford global: 4th Annual Drug Discovery USA Congress

hits:1809     Date:06/15/17

4th Annual Drug Discovery USA Congress

About conference:
Oxford Global is proud to announce that early bird registration is open for the 4th Annual Drug Discovery USA Congress, 9-10 October 2017, San Diego. Across the two days 250+ senior level attendees will join us to hear 40+ presentations and case studies giving you the chance to explore the key areas shaping this exclusive field of key therapeutic areas of Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology.
4 interactive streams
Drug Discovery Innovation and Strategies, Enabling Technologies
Phenotypic Drug Discovery, High Throughput Technologies and RNAi Screening
Discovery Chemistry: Medicinal and Computational Chemistry
Discovery Chemistry: Novel Approaches to Drug Design
A truly unmissable congress; hear from internationally renowned senior experts in the cell & gene therapy field, including:
Strategic Use of Fluorine & Analysis of the Impact of Fluorine Substitution on P-Glycoprotein Mediated Efflux, Permeability, Lipophilicity & Metabolic Stability
by Martin Pettersson, Medicinal Chemistry Team Leader, Pfizer
Chemistry & Chemical Biology Technologies for Improving Probability of Success
by Anil Vasudevan, Director, Discovery Chemistry & Technology, AbbVie
A RNAi Therapeutic Approach for Cancer Treatment
by Patrick Liu, Founder, President & CEO, Sirnaomics
Lung Specific Delivery Using Caveolae Associated Protein PV-1 Antibody Improves Drug Efficacy
by Ping Tsui, Associate Director & Principal Scientist, Antibody Discovery & Protein Engineering, MedImmune
2017 Drug Discovery USA Speakers Include:
Contact us

Angela Fernandez Saez
Tel: +447956 710599
Email: a.fernandez@oxfordglobal.co.uk

Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙